Aducanumab (BIIB037), an anti-amyloid beta monoclonal...

Alzheimer's & Dementia 2015 / 07 Vol. 11; Iss. 7

Aducanumab (BIIB037), an anti-amyloid beta monoclonal antibody, in patients with prodromal or mild Alzheimer’s disease: Interim results of a randomized, double-blind, placebo-controlled, phase 1b study

Sevigny, Jeff, Chiao, Ping, Williams, Leslie, Chen, Tianle, Ling, Yan, O’Gorman, John, Hock, Christoph, Nitsch, Roger M., Sandrock, Alfred
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2015.07.367
Date:
July, 2015
File:
PDF, 312 KB
english, 2015
Conversion to is in progress
Conversion to is failed